Intern/Policy Consulting (Life Sciences practice) - Summer 2027

<p> </p> <p><strong>About Charles River Associates</strong></p> <p><a href="https://www.crai.com/"><strong>Charles River Associates</strong></a> is a leading global consulting firm that provides economic, financial, and business management expertise to major law firms, corporations and governments around the world. CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings, and guides corporations through critical business strategy and performance-related issues. Since 1965, clients have engaged CRA for its combination of industry experience and rigorous, fact-based analysis that provide clients with clear, implementable solutions to complex business concerns.</p> <p><strong><span class="TextRun SCXW81041593 BCX8" lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW81041593 BCX8">About the Internship</span></span><span class="TextRun SCXW81041593 BCX8" lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW81041593 BCX8"> </span></span><span class="EOP Selected SCXW81041593 BCX8" data-ccp-props="{"335559738":240,"335559739":240}"> </span></strong></p> <p>CRA’s <strong><a href="https://www.crai.com/industries/life-sciences/">Life Sciences</a></strong> Practice helps pharmaceutical, biotechnology, medical devices and digital health companies achieve optimum performance across key aspects of their business including commercial strategy, pricing and access, innovation, organisation structure, policy analysis, medical affairs, stakeholder management, and reputation, all for the long-term benefit of patients, clinicians, employees, and shareholders. We work with life sciences businesses directly as well as with their legal counsel, industry associations, government organisations, and advocacy groups.</p> <p><span data-contrast="auto">The CRA Life Sciences team operates from offices across the United States, UK and Europe, providing insights on global issues and local market challenges across all geographies. </span><span data-ccp-props="{"335559738":240,"335559739":240}"> </span></p> <p><span data-ccp-props="{"335559738":240,"335559739":240}"><span data-contrast="auto">Our clients’ trust in us is rooted in our emphatic focus on clients and specifically our hands-on life sciences experience, in-depth sector knowledge, from R&D to market entry and beyond, and strong academic credentials in science, economics, policy and business.</span><span data-contrast="auto"> </span><span data-ccp-props="{"201341983":0,"335559740":276}"> </span></span></p> <p><span data-contrast="auto">Our dedicated </span><a href="https://www.crai.com/industries/life-sciences/life-sciences-policy/"><strong><span data-contrast="none"><span data-ccp-charstyle="Hyperlink">Policy team</span></span></strong></a><span data-contrast="auto"> works with Life Sciences companies, industry associations, government organizations, and advocacy groups to anticipate and respond to policy challenges. Our projects focus on analysing ongoing or anticipated policy challenges, assessing the impact on patients, competition or innovation, and helping clients with developing solutions that address these challenges whilst supporting their commercial priorities.</span><span data-contrast="auto"> </span><span data-ccp-props="{"335559738":240,"335559739":240}"> </span></p> <p><span data-contrast="auto">During your internship you may work on a variety of project types, including but not limited to:</span><span data-contrast="auto"> </span><span data-ccp-props="{"335559738":240,"335559739":240}"> </span></p> <ul> <li data-leveltext="" data-font="Symbol" data-listid="3" data-list-defn-props="{"335552541":1,"335559685":720,"335559991":360,"469769226":"Symbol","469769242":[8226],"469777803":"left","469777804":"","469777815":"hybridMultilevel"}" data-aria-posinset="1" data-aria-level="1"><strong><span data-contrast="auto">Policy projects:</span></strong><span data-contrast="auto"> helps clients anticipate how healthcare policies will evolve and what this means for access to medicines and future innovation. Projects range from US debates on drug pricing and Medicare negotiations to global challenges around cell and gene therapies, healthcare financing, and digital health</span><span data-ccp-props="{}"> </span></li> </ul> <ul> <li data-leveltext="" data-font="Symbol" data-listid="2" data-list-defn-props="{"335552541":1,"335559685":720,"335559991":360,"469769226":"Symbol","469769242":[8226],"469777803":"left","469777804":"","469777815":"multilevel"}" data-aria-posinset="6" data-aria-level="1"><strong><span data-contrast="auto">Opportunity assessment</span></strong><span data-contrast="auto">: Supporting the valuation of new therapies</span><span data-contrast="auto"> </span><span data-ccp-props="{"335559739":0}"> </span></li> </ul> <ul> <li data-leveltext="" data-font="Symbol" data-listid="2" data-list-defn-props="{"335552541":1,"335559685":720,"335559991":360,"469769226":"Symbol","469769242":[8226],"469777803":"left","469777804":"","469777815":"multilevel"}" data-aria-posinset="7" data-aria-level="1"><strong><span data-contrast="auto">Value communication</span></strong><span data-contrast="auto">: Building evidence-based narratives to demonstrate the clinical and economic value of